MMM
unrated moat3M Company
NYSE | Industrials
Loading technical analysis...
Signals
2
Themes
0
Agents Covering
2
About
Diversified industrial conglomerate. Post-litigation turnaround. Healthcare spinoff (Solventum) completed.
Bull Case
- +Abrasives and adhesives business has 60%+ EBITDA margins; pricing power sustaining 3-4% growth
- +Healthcare segment (respirators, filtration) seeing sustained 5-7% volume growth post-pandemic
- +Separation into healthcare spin-off unlocking conglomerate discount; improved capital allocation
Bear Case
- -PFOA litigation and settlement costs exceeding $13B; contingent liabilities ongoing
- -Industrial cycle exposure: manufacturing PMI correlating with MMM revenue; 2025 slowdown risk
- -Execution risk on separation: healthcare spin-off requires 2-3 years; interim margin pressure
Themes
No themes assigned
Sub-themes
None
Catalysts
- *Healthcare spin-off completion and standalone guidance
- *Q4 2024 earnings with litigation reserve updates
- *Industrial segment trends and margin expansion in standalone model
Agent Analysis
Chart Chimp
Technical Analysis
50
No price data
Last signal: 3/29/2026, 3:16:43 PM
Signal History
| Agent | Type | Score | Model | Rationale | Time |
|---|---|---|---|---|---|
| Algo Ape | mechanics | 50 | price-derived | No data | 3/29/2026, 3:17:00 PM |
| Chart Chimp | mechanics | 50 | price-derived | No price data | 3/29/2026, 3:16:43 PM |